Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, is linked to cardiovascular disease and atherogenesis (Simonet et al., 1997; Schoppet et al., 2004; Tousoulis et al., 2013). This evidence concerns the gene TNFRSF11B and cardiovascular disorder.